The trademark application was filed by Agios Pharmaceuticals, Inc, a U.S. corporation (the "Applicant"). The application was published for oppositions on June 28, 2021, and it was registered by office on October 5, 2021 without any oppositions.
The application was filed in English (German was selected as the second language).
Change of name and professional address of the trademark registration was recorded on September 5, 2021. Change of name and professional address of the trademark registration was recorded on May 23, 2022. Change of name and address of the trademark registration was recorded on June 2, 2022.